RT Journal Article
SR Electronic
T1 Urinalysis, but not blood biochemistry, detects the early renal-impairment in patients with COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.04.03.20051722
DO 10.1101/2020.04.03.20051722
A1 Zhou, Haifeng
A1 Zhang, Zili
A1 Fan, Heng
A1 Li, Junyi
A1 Li, Mingyue
A1 Dong, Yalan
A1 Guo, Weina
A1 Lin, Lan
A1 Kang, Zhenyu
A1 Yu, Ting
A1 Tian, Chunxia
A1 Gui, Yang
A1 Qin, Renjie
A1 Wang, Haijun
A1 Luo, Shanshan
A1 Hu, Desheng
YR 2020
UL http://medrxiv.org/content/early/2020/04/06/2020.04.03.20051722.abstract
AB Background In December 2019, a novel coronavirus (SARS-CoV-2) caused infectious disease, termed COVID-19, outbroke in Wuhan, China. COVID-19 patients manifested as lung injury with complications in other organs, such as liver, heart, gastrointestinal tract, especially for severe cases. However, whether COVID-19 causes significant acute kidney injury (AKI) remained controversial.Methods We retrospectively analyzed the clinical characteristics, urine and blood routine tests and other laboratory parameters of hospitalized COVID-19 patients in Wuhan Union Hospital.Findings 178 patients, admitted to Wuhan Union hospital from February 02 to February 29, 2020, were included in this study. No patient (0 [0%]) presented increased serum creatinine (Scr), and 5 (2.8%) patients showed increased blood urea nitrogen (BUN), indicating few cases with “kidney dysfunction”. However,for patients (83) with no history of kidney disease who received routine urine test upon hospitalization, 45 (54.2%) patients displayed abnormality in urinalysis, such as proteinuria, hematuria and leukocyturia, while none of the patients was recorded to have acute kidney injury (AKI) throughout the study. Meanwhile, the patients with abnormal urinalysis usually had worse disease progression reflecting by laboratory parameters presentations, including markers of liver injury, inflammation, and coagulation.Conclusion Many patients manifested by abnormal urinalysis on admission, including proteinuria or hematuria. Our results revealed that urinalysis is better in unveiling potential kidney impairment of COVID-19 patients than blood chemistry test and urinalysis could be used to reflect and predict the disease severity. We therefore recommend pay more attention in urinalysis and kidney impairment in COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by the grants from the project of Thousand Youth Talents for D.H.; and from the China National Natural Science Foundation (Nos. 31770983 and 81974249 to D.H., No. 81601747 to S.L.).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data used to support the findings of this study are available from the corresponding author upon request.